The influence of L-triiodothyronine, L-thyroxine, estradiol-17β, the luteinizing-hormone-releasing hormone, the epidermal growth factor and gastrin on cell proliferation in organ cultures of 35 benign and 13 malignant human thyroid tumors

被引:7
作者
Nagy, N
Camby, I
Decaestecker, C
Chaboteaux, C
Gras, T
Darro, F
Rocmans, P
Kiss, R
Salmon, I
机构
[1] Free Univ Brussels, Fac Med, Histol Lab, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Hop Erasme, Clin Univ Bruxelles, Serv Anatomopathol, B-1070 Brussels, Belgium
[3] Lab Louis Lafon, Maisons Alfort, France
[4] Free Univ Brussels, Hop Erasme, Clin Univ Bruxelles, Serv Chirurg Thorac, B-1070 Brussels, Belgium
关键词
human thyroid; multinodular goiters; adenomas; cancer; cell proliferation; hormone sensitivity;
D O I
10.1007/s004320050287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To characterize the influence of six factors on human thyroid tissues at the cell-proliferation level. These six factors were the epidermal growth factor (EGF), the luteinizing-hormone-releasing hormone (LHRH), triiodothyronine, thyroxine, estradiol and gastrin. Methods: Forty-eight human thyroid specimens were obtained from surgical resection and maintained alive for 48 h ex vivo (in vitro) under organotypic culture conditions. These specimens comprised 35 benign cases (17 multinodular goiters and 18 adenomas) and 13 cancers. Cell proliferation in the control and treated conditions (at a 5 nM dose) was assessed by means of the thymidine labeling index, which enables the percentage of cells in the S phase of the cell cycle to be determined in accordance with autoradiographic procedures. Results: The results show that, of the six factors tested here, EGF significantly (P < 0.05 to P < 0.001) increased cell proliferation in the greatest number of cancers as compared to what happened with the remaining five. Each of these six factors significantly increased or decreased proliferative cell activity in some 10%-30% of the cases under study. Conclusions: Triiodothyronine, thyroxine, LHRH and gastrin may increase or decrease cell proliferation in human thyroid tissues, whether benign or malignant, to the same extent as other hormones and/or growth factors such as thyrotropin, EGF, insulin-like growth factor 1, transforming growth factor beta 1 and estradiol the effects of which on thyroid cell proliferation are already well documented in the literature.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 63 条
[51]   PLOIDY LEVEL AND PROLIFERATIVE ACTIVITY MEASUREMENTS IN A SERIES OF 407 THYROID-TUMORS OR OTHER PATHOLOGICAL CONDITIONS [J].
SALMON, I ;
GASPERIN, P ;
REMMELINK, M ;
RAHIER, I ;
ROCMANS, P ;
PASTEELS, JL ;
HEIMANN, R ;
KISS, R .
HUMAN PATHOLOGY, 1993, 24 (08) :912-920
[52]   DIRECT EFFECTS OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS AND ANTAGONISTS ON MCF-7 MAMMARY-CANCER CELLS [J].
SEGALABRAMSON, T ;
KITROSER, H ;
LEVY, J ;
SCHALLY, AV ;
SHARONI, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2336-2339
[53]   GROWTH-PROMOTING EFFECTS OF GLYCINE-EXTENDED PROGASTRIN [J].
SEVA, C ;
DICKINSON, CJ ;
YAMADA, T .
SCIENCE, 1994, 265 (5170) :410-412
[54]   THYROID-HORMONE ENHANCEMENT OF ESTRADIOL STIMULATION OF BREAST-CARCINOMA PROLIFERATION [J].
SHAO, ZM ;
SHEIKH, MS ;
RISHI, AK ;
DAWSON, MI ;
LI, XS ;
WILBER, JF ;
FENG, P ;
FONTANA, JA .
EXPERIMENTAL CELL RESEARCH, 1995, 218 (01) :1-8
[55]   Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines [J].
Soh, EY ;
Sobhi, SA ;
Wong, MG ;
Meng, YG ;
Siperstein, AE ;
Clark, OH ;
Duh, QY .
SURGERY, 1996, 120 (06) :944-947
[56]   LAMININ MEDIATES TISSUE-SPECIFIC GENE-EXPRESSION IN MAMMARY EPITHELIA [J].
STREULI, CH ;
SCHMIDHAUSER, C ;
BAILEY, N ;
YURCHENCO, P ;
SKUBITZ, APN ;
ROSKELLEY, C ;
BISSELL, MJ .
JOURNAL OF CELL BIOLOGY, 1995, 129 (03) :591-603
[57]   HISTOMORPHOLOGICAL AND IMMUNOHISTOCHEMICAL EVIDENCE THAT HUMAN NODULAR GOITERS GROW BY EPISODIC REPLICATION OF MULTIPLE CLUSTERS OF THYROID FOLLICULAR CELLS [J].
STUDER, H ;
GERBER, H ;
ZBAEREN, J ;
PETER, HJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04) :1151-1158
[58]   ROLE OF THYROID STIMULATING HORMONE SUPPRESSION IN THE MANAGEMENT OF THYROID-CANCER [J].
THOMAS, CG .
SEMINARS IN SURGICAL ONCOLOGY, 1991, 7 (02) :115-119
[59]  
VANSOLINGE WW, 1993, CANCER RES, V53, P1823
[60]   EXPRESSION BUT INCOMPLETE MATURATION OF PROGASTRIN IN COLORECTAL CARCINOMAS [J].
VANSOLINGE, WW ;
NIELSEN, FC ;
FRIISHANSEN, L ;
FALKMER, UG ;
REHFELD, JF .
GASTROENTEROLOGY, 1993, 104 (04) :1099-1107